Growth Metrics

Bionano Genomics (BNGO) Gains from Investment Securities (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Gains from Investment Securities for 7 consecutive years, with $371000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 107.93% to $371000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $71000.0 through Dec 2025, up 100.63% year-over-year, with the annual reading at $150000.0 for FY2025, 167.86% up from the prior year.
  • Gains from Investment Securities hit $371000.0 in Q4 2025 for Bionano Genomics, up from -$300000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.3 million in Q3 2021 to a low of -$5.1 million in Q2 2024.
  • Historically, Gains from Investment Securities has averaged -$804533.3 across 5 years, with a median of -$8000.0 in 2022.
  • Biggest five-year swings in Gains from Investment Securities: soared 462.5% in 2023 and later crashed 17786.21% in 2024.
  • Year by year, Gains from Investment Securities stood at -$2.3 million in 2021, then skyrocketed by 122.39% to $517000.0 in 2022, then plummeted by 378.34% to -$1.4 million in 2023, then plummeted by 225.09% to -$4.7 million in 2024, then soared by 107.93% to $371000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for BNGO at $371000.0 in Q4 2025, -$300000.0 in Q2 2025, and -$4.7 million in Q4 2024.